发明名称 Novel anti-IGF-IR antibodies and uses thereof
摘要 Disclosed is an isolated antibody, or one of its functional fragments, said antibody or one of its said fragments being capable of binding to the human insulin-like growth factor I receptor IGF-IR and inhibiting the natural attachment of its ligands IGF1 and/or IGF2 and/or capable of specifically inhibiting the tyrosine kinase activity of said IGF-IR, comprising: - a light chain comprising at least three complementarity determining regions CDR of specific sequences, or three CDRs whose sequences have at least 80% identity after optimum alignment with the specific disclosed sequences; and - a heavy chain comprising at least three CDRs of specific sequences, or three CDRs whose sequence have at least 80% identity after optimum alignment with the specific disclosed sequences. (62) Divided Out of 552821
申请公布号 NZ569718(A) 申请公布日期 2010.03.26
申请号 NZ20050569718 申请日期 2005.07.27
申请人 PIERRE FABRE MEDICAMENT 发明人 GOETSCH, LILIANE;CORVAIA, NATHALIE
分类号 C07K16/28;A61K39/395;A61P17/06;A61P35/00;C12N5/18;C12N15/13;G01N33/577 主分类号 C07K16/28
代理机构 代理人
主权项
地址